EASL-EASD-EASO Guidance for the Use of Resmetirom and Semaglutide as MASH-Targeted Therapy.
Listen to this summary
This joint EASL-EASD-EASO guidance addresses how to use resmetirom (80/100 mg orally) and semaglutide (2.4 mg weekly subcutaneously) as MASH-targeted therapies in adults with metabolic dysfunction-associated steatohepatitis, covering candidate selection, initiation, monitoring, and discontinuation. The authors recommend pharmacotherapy for non-cirrhotic MASH with fibrosis stages 2-3, with the choice individualized by cardiometabolic profile: semaglutide is preferred for patients with obesity, type 2 diabetes, or established cardiovascular disease, while resmetirom may be prioritized for those without obesity or already on or intolerant to GLP-1 receptor agonists. In MASH cirrhosis, the drugs appear safe but are not recommended as MASH-targeted treatment until liver-related benefits are demonstrated.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Journal of hepatology
View all →Nov 19, 2026 · Journal of hepatology
Checkpoint Inhibition during primary hepatitis E virus infection alters memory development of virus-specific T-cells in humans.
Nov 13, 2026 · Journal of hepatology
Translocation of the environmental bacterium Aquitalea magnusonii promotes systemic inflammation and liver fibrosis in chronic liver disease.
Nov 10, 2026 · Journal of hepatology
Senescence induces clonal failure of hepatocyte plasticity and reshapes regenerative lineages.
Nov 8, 2026 · Journal of hepatology
Seladelpar for alkaline phosphatase normalization in primary biliary cholangitis: The IDEAL phase III randomized controlled trial.
Nov 2, 2026 · Journal of hepatology
Liver biopsy confirms precise and efficient correction of SERPINA1 after in vivo Base Editing in a Patient with Alpha-1 Antitrypsin Deficiency.
Oct 28, 2026 · Journal of hepatology
Crosstalk along the gut-liver axis in liver disease: Clinical and mechanistic aspects.
More in Internal Medicine
View all →Nov 21, 2026 · Journal of pain and symptom management
Psychosocial Profiles of Homebound Adults with Cancer and Poor Symptom Control: A Cluster Analysis of Meaning, Distress, and Desire for Hastened Death.
Nov 21, 2026 · Chest
Cardiopulmonary exercise testing responses to treatment in patients with pulmonary arterial hypertension and cardiopulmonary comorbidities.
Nov 21, 2026 · Journal of pain and symptom management
Documenting Psychosocial Needs at the End of Life: Implementation of an Interdisciplinary Huddle to Foster Communication in Pediatric Care.
Nov 21, 2026 · Chest
Association between exertional dyspnea and insomnia in a population-based cohort.
Nov 21, 2026 · Chest
Real-World Outcomes of Long-Acting Beta-Agonist Add-On Therapy to Inhaled Corticosteroids in Preschool Children with Asthma: A Multicenter Retrospective Study.
Nov 21, 2026 · Chest
Combination acetazolamide and supplemental oxygen markedly improves ventilatory control instability and OSA severity.
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


